Search Results 481-490 of 16319 for monoclonal antibody

1. Consultations - Antibody Hybridoma Core - Mayo Clinic Research

   Topics discussed during this consultation include: Strategies for immunization, and antibody screening and production; Type, form and amount of antigen(s) to be ...

2. Cutaneous T-Cell Lymphoma Clinical Trials - Mayo Clinic Research

   Monoclonal antibodies, such as pembrolizumab, may interfere with the ability of tumor cells to grow and spread. Giving dendritic cell therapy, cryosurgery and ...

3. A Study to Compare Three Chemotherapy Regimens for the Treatment of Patients with Newly- diagnosed Mantle Cell Lymphoma - Mayo Clinic

   Monoclonal antibodies, such as rituximab, may interfere with the ability of cancer cells to grow and spread. Acalabrutinib may stop the growth of cancer ...

4. Epidemiology of Monoclonal B-Cell Lymphocytosis Study - B-Cell Lymphoproliferative Disorders - Mayo Clinic Research

   The Slager B-Cell Lymphoproliferative Disorders Lab at Mayo Clinic is studying connections between monoclonal B-cell lymphocytosis and blood and lymph node ...

5. Small Cell Lung Cancer Clinical Trials - Mayo Clinic Research

   Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of ...

6. Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With RAS Wild-Type Locally Advanced or Metastatic Colorectal Cancer That Cannot Be Removed by Surgery - Mayo Clinic

   Irinotecan may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Monoclonal antibodies, such as cetuximab and bevacizumab, ...

7. Family Study of Monoclonal B-Cell Lymphocytosis (MBL) - Mayo Clinic

   About this study. Given that family members of CLL patients are known to have an increased risk of CLL (on the order of 8-fold), and they have a higher ...

8. Oncology (Medical) - Clinical trials - Mayo Clinic

   Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of ...

9. Randomized Phase II/III Trial of Adjuvant Radiation Therapy with Cisplatin, Docetaxel-Cetuximab, or Cisplatin-Atezolizumab in Pathologic High-Risk Squamous Cell Cancer of the Head and Neck - Mayo Clinic

   Monoclonal antibodies, such as cetuximab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find ...

10. HER2-Positive Breast Cancer Clinical Trials - Mayo Clinic Research

    Monoclonal antibodies, such as trastuzumab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find ...